Gaurav Goparaju
Stock Analyst at Berenberg
(0.16)
# 4,062
Out of 4,670 analysts
7
Total ratings
12.5%
Success rate
-16.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Goparaju
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiates: Buy | $27 | $42.23 | -36.06% | 1 | Sep 27, 2023 | |
| DNA Ginkgo Bioworks Holdings | Initiates: Buy | $240 | $7.18 | +3,242.62% | 1 | Nov 29, 2022 | |
| ME 23andMe Holding Co. | Initiates: Buy | $140 | $3.11 | +4,401.61% | 1 | Nov 29, 2022 | |
| CERT Certara | Initiates: Buy | $23 | $10.36 | +122.01% | 1 | Sep 8, 2022 | |
| ABSI Absci | Initiates: Buy | $28 | $2.56 | +993.75% | 1 | Feb 1, 2022 | |
| RLAY Relay Therapeutics | Initiates: Buy | $45 | $4.75 | +847.37% | 1 | Feb 1, 2022 | |
| SDGR Schrödinger | Initiates: Buy | $91 | $20.84 | +336.66% | 1 | Oct 13, 2021 |
Twist Bioscience
Sep 27, 2023
Initiates: Buy
Price Target: $27
Current: $42.23
Upside: -36.06%
Ginkgo Bioworks Holdings
Nov 29, 2022
Initiates: Buy
Price Target: $240
Current: $7.18
Upside: +3,242.62%
23andMe Holding Co.
Nov 29, 2022
Initiates: Buy
Price Target: $140
Current: $3.11
Upside: +4,401.61%
Certara
Sep 8, 2022
Initiates: Buy
Price Target: $23
Current: $10.36
Upside: +122.01%
Absci
Feb 1, 2022
Initiates: Buy
Price Target: $28
Current: $2.56
Upside: +993.75%
Relay Therapeutics
Feb 1, 2022
Initiates: Buy
Price Target: $45
Current: $4.75
Upside: +847.37%
Schrödinger
Oct 13, 2021
Initiates: Buy
Price Target: $91
Current: $20.84
Upside: +336.66%